Inogen Inc. Files 8-K on Financials
Ticker: INGN · Form: 8-K · Filed: Aug 6, 2024 · CIK: 1294133
| Field | Detail |
|---|---|
| Company | Inogen Inc (INGN) |
| Form Type | 8-K |
| Filed Date | Aug 6, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-condition, results-of-operations
Related Tickers: INGN
TL;DR
Inogen filed an 8-K today, expect financial updates soon.
AI Summary
On August 6, 2024, Inogen Inc. filed an 8-K report. The filing primarily concerns the company's financial condition and results of operations, indicating a need to update stakeholders on its financial performance. No specific financial figures or significant events were detailed in the provided excerpt.
Why It Matters
This filing signals an update on Inogen's financial health and operational results, which is crucial for investors to assess the company's current standing and future prospects.
Risk Assessment
Risk Level: low — The filing is a standard procedural report and does not contain information that inherently increases risk.
Key Players & Entities
- Inogen Inc. (company) — Registrant
- August 06, 2024 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- 859 Ward Drive (address) — Principal Executive Offices
- Goleta, California (location) — City, State of Principal Executive Offices
FAQ
What specific financial information is being reported in this 8-K filing?
The provided excerpt indicates the filing pertains to 'Results of Operations and Financial Condition' and 'Financial Statements and Exhibits', but does not detail the specific financial figures within this section.
When was the earliest event reported in this Form 8-K?
The earliest event reported in this Form 8-K was on August 06, 2024.
What is Inogen Inc.'s principal executive office address?
Inogen Inc.'s principal executive office is located at 859 Ward Drive, Goleta, California, 93111.
Under which section of the Securities Exchange Act is this report filed?
This report is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
What is Inogen Inc.'s fiscal year end?
Inogen Inc.'s fiscal year ends on December 31st (1231).
Filing Stats: 504 words · 2 min read · ~2 pages · Grade level 11.3 · Accepted 2024-08-06 16:10:10
Key Financial Figures
- $0.001 — nge on which registered Common Stock, $0.001 par value INGN The Nasdaq Stock Mar
Filing Documents
- ingn-20240806.htm (8-K) — 39KB
- ingn-ex99_1.htm (EX-99.1) — 638KB
- img132417817_0.jpg (GRAPHIC) — 3KB
- 0000950170-24-091800.txt ( ) — 813KB
- ingn-20240806.xsd (EX-101.SCH) — 23KB
- ingn-20240806_htm.xml (XML) — 4KB
02 Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition. On August 6, 2024, Inogen, Inc. (the "Company") issued a press release reporting its financial results for the second quarter ended June 30, 2024. A copy of the press release is furnished herewith as Exhibit 99.1 to this Current Report on Form 8-K. The information furnished in this Current Report under Item 2.02 and the exhibit attached hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or incorporated by reference in any filing under the Securities Act of 1933, as amended (the "Securities Act"), or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit Description 99.1 Press Release dated August 6, 2024. 104 The cover page of this Current Report on Form 8-K, formatted in Inline XBRL.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. INOGEN, INC. Date: August 6, 2024 By: /s/ Michael Bourque Michael Bourque Executive Vice President Chief Financial Officer Treasurer (Principal Accounting and Financial Officer)